Applications including "Pharmaceuticals"

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LC Technical Note InertSustain AQ-C18 InertSustain PFP
GA113 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap Pure-WAX
LB990 - Analysis of Xylazine -

LC InertSearch Inertsil WP300 C18
LB989 - Analysis of Xylazine -

LC InertSearch InertSustain C18
LB988 - Analysis of Xylazine -

LC InertSearch InertSustainSwift C8
LB987 - Analysis of Xylazine -

LC InertSearch Inertsil WP300 C18
LB986 - Analysis of Ganciclovir -

LC InertSearch Inertsil ODS-3
LB985 - Analysis of Sumatriptan -

LC InertSearch Inertsil ODS-3
LB984 - Analysis of Sumatriptan -

LC InertSearch InertSustain AQ-C18
LB983 - Analysis of Lornoxicam -

LC InertSearch Inertsil ODS-4
LB982 - Analysis of Ofloxacin -

LC InertSearch InertSustain C18
LB981 - Analysis of Ofloxacin -

LC InertSearch Inertsil WP300 C18
LB980 - Analysis of Desloratadine -

LC InertSearch InertSustain AQ-C18
LB979 - Analysis of Desloratadine -

LC InertSearch InertSustain Cyano
LB978 - Analysis of Hydrochlorothiazide -

LC InertSearch InertSustain AQ-C18
LB977 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain AQ-C18
LB976 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB975 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB974 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB973 - Analysis of Dapagliflozin propandiol -

LC InertSearch InertSustain C18
LB972 - Analysis of Acyclovir -

LC InertSearch InertSustain C18
LB971 - Analysis of Acyclovir -

LC InertSearch InertSustain C18
LB970 - Analysis of Acyclovir -

LC InertSearch InertSustain C18
LB969 - Analysis of Acyclovir -

LC InertSearch InertSustainSwift C18
LB968 - Analysis of Acyclovir -

LC InertSearch Inertsil WP300 C18
LB965 - Analysis of Nicardipine Hydrochloride -

LC InertSearch InertSustain C8
LB961 - Analysis of Lidocaine -

LC InertSearch Insertsil WP300 C18
LB960 - Analysis of Lidocaine -

LC InertSearch Insertsil WP300 C18
GA382 - Analysis of Menthol -

GC InertSearch InertCap Pure-WAX
GA381 - Analysis of Residual solvents in pharmaceuticals (Class 3) -

GC InertSearch InertCap Pure-WAX
GA380 - Analysis of Residual solvents in pharmaceuticals (Class 3) -

GC InertSearch InertCap 624MS
LB958 - Analysis of Methyltestosterone and Progesterone -

LC InertSearch Insertsil WP300 C18
LB956 - Analysis of Sumatriptan succinate and Naproxen Sodium -

LC InertSearch Insertsil Ph-3
GA375 - Analysis of Residual solvents in pharmaceuticals (Class 2E) -

GC InertSearch InertCap Pure-WAX
GA374 - Analysis of Residual solvents in pharmaceuticals (Class 2E) -

GC InertSearch InertCap 624MS
GA373 - Analysis of Residual solvents in pharmaceuticals (Class 2E) -

GC InertSearch InertCap 624MS
GA372 - Analysis of Residual solvents in pharmaceuticals (Class 2D) -

GC InertSearch InertCap Pure-WAX
GA371 - Analysis of Residual solvents in pharmaceuticals (Class 2D) -

GC InertSearch InertCap 624MS
GA370 - Analysis of Residual solvents in pharmaceuticals (Class 2D) -

GC InertSearch InertCap 624MS
LB953 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets, Pregabalin Capsules) -

LC InertSearch InertSustain Cyano
LB952 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets) -

LC InertSearch InertSustain C18
LB951 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Capsules) -

LC InertSearch InertSustain C18
LB950 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin) -

LC InertSearch InertSustain C18
LB948 - Analysis of Omeprazole -

LC InertSearch Inertsil C8-3
LB946 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB945 - Analysis of Glacial Acetic Acid -

LC InertSearch InertSustain AQ-C18
LB944 - Analysis of Amikacin sulfate -

LC InertSearch InertSustainSwift C18
LB943 - Analysis of Amikacin -

LC InertSearch InertSustainSwift C18
LB939 - Analysis of Potassium sucrose octasulfate -

LC InertSearch Inertsil NH2
LB938 - Analysis of Galantamine -

LC InertSearch InertSustain C18
LB937 - Analysis of Febuxostat -

LC InertSearch Inertsil ODS-4
LB936 - Analysis of Febuxostat -

LC InertSearch InertSustain C30
LB935 - Analysis of Febuxostat -

LC InertSearch InertSustain AQ-C18
LB934 - Analysis of Methylpyrazines -

LC InertSearch InertSustain C18
LB933 - Analysis of Diclofenac sodium -

LC InertSearch Inertsil WP300 C18
LB931 - Analysis of Acyclovir -

LC InertSearch Inertsil ODS-3
LB930 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB929 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB928 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB927 - Analysis of Blonanserin -

LC InertSearch InertSustain C18
LB926 - Analysis of Piperacillin Sodium -

LC InertSearch Inertsil WP300 C18
LB925 - Analysis of Acyclovir -

LC InertSearch InertSustain Cyano
LB924 - Analysis of Acyclovir -

LC InertSearch InertSustain Cyano
LB922 - Analysis of 4 Drugs -

LC InertSearch InertSustai AQ-C18 InertSustain AQ-C18
LB921 - Analysis of 4 Drugs -

LC InertSearch Inertsil ODS-4
LB919 - Analysis of Pitavastatin Calcium -

LC InertSearch InertCore Plus C18
LB916 - Analysis of Metformin Hydrochloride -

LC InertSearch InertSustain C18
LB915 - Analysis of Metformin Hydrochloride -

LC InertSearch InertSustain C18
LB914 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB913 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB912 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB911 - Analysis of Metformin Hydrochloride -

LC InertSearch Inertsil WP300 C18
LB907 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB906 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB905 - Analysis of Aripiprazole -

LC InertSearch InertSustain C18
LB904 - Analysis of Celecoxib -

LC InertSearch Inertsil Ph-3
LB903 - Analysis of Perospirone hydrochloride -

LC InertSearch InertSustain C18
LB902 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB901 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18
LB900 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustain C8
LB899 - Analysis of Fesoterodine Fumarate -

LC InertSearch InertSustainSwift C18
GA351 - Analysis of Dextran 40 -

GC InertSearch InertCap 1
GA350 - Analysis of Acrylic Acid and Methyl Methacrylate -

GC InertSearch InertCap 1
LB896 - Analysis of Triptorelin Pamoate -

LC InertSearch InertSustain C18
LB895 - Analysis of Venlafaxine hydrochloride -

LC InertSearch InertSustainSwift C8
LB894 - Analysis of Ursodiol -

LC InertSearch Inertsil WP300
LB891 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB890 - Analysis of Saxagliptin -

LC InertSearch InertSustain C18 HP
LB889 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB888 - Analysis of Propyl gallate -

LC InertSearch Inertsil WP300
LB887 - Analysis of Propyl gallate -

LC InertSearch Inertsil ODS-4
LB885 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB884 - Analysis of Voriconazole -

LC InertSearch InertSustain C18
LB883 - Analysis of Paclitaxel -

LC InertSearch InertSustain PFP
LB882 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch InertSustain C18
LB881 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB880 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch InertSustain C18
LB879 - Analysis of Paracetamol and Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB878 - Analysis of Mefenamic acid -

LC InertSearch InertSustain C18
LB877 - Analysis of Mefenamic acid -

LC InertSearch Inertsil ODS-3
LB876 - Analysis of Cefoxitin -

LC InertSearch InertSustain C18
LB875 - Analysis of Levofloxacin -

LC InertSearch Inertsil ODS-3
LB874 - Analysis of Captopril and Captopril Disulfide -

LC InertSearch InertSustain AQ-C18
LB873 - Tacrolimus Extended-Release Capsules -

LC InertSearch InertSustain AQ-C18
LB872 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB871 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB870 - Analysis of Febuxostat -

LC InertSearch InertSustain Phenyl
LB867 - Analysis of Febuxostat -

LC InertSearch InertSustain C18
LB849 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB848 - Analysis of Tolvaptan (Under the Condition of the draft for the Japanese Pharmacopoeia 18th SupplementII) -

LC InertSearch Inertsil ODS-4
LB837 - Analysis of Nonsteroidal anti-inflammatory drug -

LC InertSearch InertSustain C30
LB827 - Analysis of Clobetasone butyrate standard -

LC InertSearch InertSustainSwift C18
LB823 - Analysis of Glycyrrhiza -

LC InertSearch Inertsil ODS-3
LB816 - Analysis of Zoledronic acid -

LC InertSearch InertSustainSwift C18
LB815 - Analysis of Riboflavin (Vitamin B2) and its metabolites -

LC InertSearch InertSustainSwift C18
LB814 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AQ-C18
LB806 - Analysis of Ampicillin and Sulbactam (Under the Condition of the Japanese Pharmacopoeia 18th , Ampicillin Sodium and Sulbactam Sodium for Injection) -

LC InertSearch Inertsil ODS-HL
LB804 - Analysis of Metformin -

LC InertSearch Inertsil CX
LB803 - Simultaneous analysis of Amino acids derivatized with 4-fluoro-7-nitro-2,1,3-benzoxadiazole (NBD-F) -

LC InertSearch InertSustain C30
LB789 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB788 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB787 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB786 - Analysis of Oligonucleotides -

LC InertSearch InertSustain AX-C18
LB779 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AX-C18
LB778 - Analysis of Coenzyme A (CoA) -

LC InertSearch InertSustain AX-C18
LB773 - Analysis of Nicotinamide adenine dinucleotide and Nicotinamide adenine dinucleotide phosphate (NAD+, NADH, NADP+, NADPH) -

LC InertSearch InertSustain AX-C18
LB772 - Analysis of Nicotinamide adenine dinucleotide (NADH, NAD+) -

LC InertSearch InertSustain AX-C18
LB771 - Analysis of Nucleoside and Nucleic acid base -

LC InertSearch InertSustain AX-C18
LB769 - Analysis of Thiamine and Thiamine pyrophosphate -

LC InertSearch InertSustain AX-C18
LB768 - Analysis of Low molecular weight Hyaluronic acid -

LC InertSearch InertSustain AX-C18
LB767 - Analysis of Chondroitin Sulfate -

LC InertSearch InertSustain AX-C18
LB762 - Analysis of L-Cysteic acid -

LC InertSearch InertSustain AX-C18
LB761 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch Inertsil ODS-4
LB760 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB759 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain AX-C18
LB758 - Analysis of Doripenem (Under the Condition of the Japanese Pharmacopoeia 18th, Doripenem Hydrate) -

LC InertSearch InertSustain C18
LB757 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB756 - Analysis of Fenofibrate (Under the Condition of the Japanese Pharmacopoeia 18th) -

LC InertSearch Inertsil ODS-4
LB755 - Analysis of Oxaliplatin (Under the Condition of the draft for the Japanese Pharmacopoeia18th supplement II) -

LC InertSearch InertSustainSwift C18
LB754 - Analysis of Saccharin (Under the Condition of the Japanese Pharmacopoeia 18th, Saccharin Sodium Hydrate) -

LC InertSearch Inertsil WP300 C18
LB740 - Analysis of Acetaminophen -

LC InertSearch Inertsil ODS-3
LB739 - Analysis of Acetaminophen -

LC InertSearch Inertsil ODS-3
LB738 - Analysis of Remdesivir -

LC InertSearch InertSustain AX-C18
LB737 - Analysis of Favipiravir -

LC InertSearch InertSustain AX-C18
LB736 - Analysis of Antidepressants -

LC InertSearch InertSustain AX-C18
LB735 - Analysis of Antihistamines -

LC InertSearch InertSustain AX-C18
LB733 - Analysis of Water-soluble Vitamins -

LC InertSearch InertSustain AX-C18
LB730 - Analysis of Glutathione -

LC InertSearch InertSustain AX-C18
LB729 - Analysis of L-Cystine and L-Cysteine and L-Cysteic acid -

LC InertSearch InertSustain AX-C18
LB722 - Analysis of Ethenzamide -

LC InertSearch InertSustain C18
LB721 - Analysis of Acetaminophen -

LC InertSearch InertSustain C18
LB720 - Analysis of Acetylsalicilic acid -

LC InertSearch InertSustain C18
GA342 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap WAX
GA341 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap WAX
GA340 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap WAX
GA339 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap 624MS
GA338 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap 624MS
GA337 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap 624MS
LB702 - Analysis of ibuprofen -

LC InertSearch InertSustain C18
LB701 - Analysis of chlorpheniramine maleate -

LC InertSearch Inertsil ODS-4
LB700 - Analysis of acetaminophen -

LC InertSearch InertSustain C18
LB698 - Analysis of Neomycin Sulfate (European Pharmacopoeia 11.0th Edition, Purity Test) -

LC InertSearch InertSustain C18
LB692 - Analysis of Nitrosamines -

LC InertSearch InertSustain AQ-C18
LB691 - Analysis of Nitrosamines -

LC InertSearch InertSustain PFP
GA333 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GC InertSearch InertCap WAX
GA332 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GC InertSearch InertCap 624MS
GA331 - Residual solvents in pharmaceuticals (JP 18 Standard stock solution Class 2 C) -

GC InertSearch InertCap 624MS
GA330 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap WAX
GA329 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap 624MS
GA328 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 B) -

GC InertSearch InertCap 624MS
GA327 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap WAX
GA326 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap 624MS
GA325 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 2 A) -

GC InertSearch InertCap 624MS
GA324 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap WAX
GA323 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap 624MS
GA322 - Residual solvents in pharmaceuticals (JP18 Standard stock solution Class 1) -

GC InertSearch InertCap 624MS
LB690 - Analysis of Nitrosamines -

LC InertSearch InertSustain PFP
GA319 - Residual solvents in pharmaceuticals (Class 3) -

GC InertSearch InertCap Pure-WAX
GA318 - Residual solvents in pharmaceuticals (Class 3) -

GC InertSearch InertCap 624MS
LT051 - Analysis of Allantoin in Cosmetics Using HILIC HPLC -

LC Technical Note Inertsil HILIC
GT115 - Purity Test of Sucralose, Pharmaceutical Excipients Standard 2018 -

GC Technical Note InertCap 624MS
GT036 - Analysis of Residual Solvent Components in Pharmaceutical Products - Using InertCap 5 -

GC Technical Note InertCap 5
GT035 - Analysis of Residual Solvent Components in Drugs - Using InertCap 624 -

GC Technical Note InertCap 624
GA288 - Residual solvents in pharmaceuticals (Class 2B) -

GC InertSearch InertCap 624MS
GA287 - Residual solvents in pharmaceuticals (Class 2A) -

GC InertSearch InertCap 624MS
GA286 - Residual solvents in pharmaceuticals (Class 1) -

GC InertSearch InertCap 624MS
GA281 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap WAX
GA128 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap 5
GA127 - Residual solvents in pharmaceuticals Class3 -

GC InertSearch InertCap 5
GA126 - Residual solvents in pharmaceuticals Class2 -

GC InertSearch InertCap 5
GA125 - Residual solvents in pharmaceuticals Class1 -

GC InertSearch InertCap 5
GA124 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap 5
GA123 - Residual solvents in pharmaceuticals -

GC InertSearch InertCap 624
GA094 - Residual solvents in pharmaceuticals Class3 -

GC InertSearch InertCap Pure-WAX
GA093 - Residual solvents in pharmaceuticals Class3 -

GC InertSearch InertCap 624
GA092 - Residual solvents in pharmaceuticals Class2 -

GC InertSearch InertCap Pure-WAX
GA091 - Residual solvents in pharmaceuticals Class2 -

GC InertSearch InertCap 624
GA090 - Residual solvents in pharmaceuticals Class1 -

GC InertSearch InertCap Pure-WAX
GA089 - Residual solvents in pharmaceuticals Class1 -

GC InertSearch InertCap 624

Applications including "Pharmaceuticals"

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

GA113 - Residual solvents in pharmaceuticals -

LB990 - Analysis of Xylazine -

LB989 - Analysis of Xylazine -

LB988 - Analysis of Xylazine -

LB987 - Analysis of Xylazine -

LB986 - Analysis of Ganciclovir -

LB985 - Analysis of Sumatriptan -

LB984 - Analysis of Sumatriptan -

LB983 - Analysis of Lornoxicam -

LB982 - Analysis of Ofloxacin -

LB981 - Analysis of Ofloxacin -

LB980 - Analysis of Desloratadine -

LB979 - Analysis of Desloratadine -

LB978 - Analysis of Hydrochlorothiazide -

LB977 - Analysis of Dapagliflozin propandiol -

LB976 - Analysis of Dapagliflozin propandiol -

LB975 - Analysis of Dapagliflozin propandiol -

LB974 - Analysis of Dapagliflozin propandiol -

LB973 - Analysis of Dapagliflozin propandiol -

LB972 - Analysis of Acyclovir -

LB971 - Analysis of Acyclovir -

LB970 - Analysis of Acyclovir -

LB969 - Analysis of Acyclovir -

LB968 - Analysis of Acyclovir -

LB965 - Analysis of Nicardipine Hydrochloride -

LB961 - Analysis of Lidocaine -

LB960 - Analysis of Lidocaine -

GA382 - Analysis of Menthol -

GA381 - Analysis of Residual solvents in pharmaceuticals (Class 3) -

GA380 - Analysis of Residual solvents in pharmaceuticals (Class 3) -

LB958 - Analysis of Methyltestosterone and Progesterone -

LB956 - Analysis of Sumatriptan succinate and Naproxen Sodium -

GA375 - Analysis of Residual solvents in pharmaceuticals (Class 2E) -

GA374 - Analysis of Residual solvents in pharmaceuticals (Class 2E) -

GA373 - Analysis of Residual solvents in pharmaceuticals (Class 2E) -

GA372 - Analysis of Residual solvents in pharmaceuticals (Class 2D) -

GA371 - Analysis of Residual solvents in pharmaceuticals (Class 2D) -

GA370 - Analysis of Residual solvents in pharmaceuticals (Class 2D) -

LB953 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets, Pregabalin Capsules) -

LB952 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Orally Disintegrating Tablets) -

LB951 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin Capsules) -

LB950 - Analysis of Pregabalin (Under the Condition of the draft for the Japanese Pharmacopoeia, Pregabalin) -

LB948 - Analysis of Omeprazole -

LB946 - Analysis of Glacial Acetic Acid -

LB945 - Analysis of Glacial Acetic Acid -

LB944 - Analysis of Amikacin sulfate -

LB943 - Analysis of Amikacin -

LB939 - Analysis of Potassium sucrose octasulfate -

LB938 - Analysis of Galantamine -

LB937 - Analysis of Febuxostat -

LB936 - Analysis of Febuxostat -

LB935 - Analysis of Febuxostat -

LB934 - Analysis of Methylpyrazines -

LB933 - Analysis of Diclofenac sodium -

LB931 - Analysis of Acyclovir -

LB930 - Analysis of Blonanserin -

LB929 - Analysis of Blonanserin -

LB928 - Analysis of Blonanserin -

LB927 - Analysis of Blonanserin -

LB926 - Analysis of Piperacillin Sodium -

LB925 - Analysis of Acyclovir -

LB924 - Analysis of Acyclovir -

LB922 - Analysis of 4 Drugs -

LB921 - Analysis of 4 Drugs -

LB919 - Analysis of Pitavastatin Calcium -

LB916 - Analysis of Metformin Hydrochloride -

LB915 - Analysis of Metformin Hydrochloride -

LB914 - Analysis of Saxagliptin -

LB913 - Analysis of Saxagliptin -

LB912 - Analysis of Metformin Hydrochloride -

LB911 - Analysis of Metformin Hydrochloride -

LB907 - Analysis of Aripiprazole -

LB906 - Analysis of Aripiprazole -

LB905 - Analysis of Aripiprazole -

LB904 - Analysis of Celecoxib -

LB903 - Analysis of Perospirone hydrochloride -

LB902 - Analysis of Saxagliptin -

LB901 - Analysis of Saxagliptin -